WELLNESS THERAPY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
WELLNESS THERAPY
Largest movements
- Receivables within one year -€10,540
down €10,540 (-13.3%), from €78,989 to €68,449
- Cash +€1,222
up €1,222 (+29.6%), from €4,126 to €5,348
mainly Receivables within one year (+€10,540) and Other debts (+€8,301)
- Tax, wage and social debts -€17,060
no longer reported in 2025 (was €17,060)
of which Remuneration and social security: -€17,060
- Other debts +€8,301
up €8,301 (+11.2%), from €73,831 to €82,132
- Trade debts -€2,072
down €2,072 (-94.6%), from €2,191 to €119
- Profit (loss) carried forward +€1,514
up €1,514 (+3.2%), from -€47,513 to -€45,999
- Gross operating margin -€10,431
down €10,431 (-72.9%), from €14,303 to €3,871
- Depreciation -€395
no longer reported in 2025 (was €395)
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €85,637 | €76,319 | -€9,317 | -10.9% |
| Current assets | 29/58 | €85,637 | €76,319 | -€9,317 | -10.9% |
| Amounts receivable within one year | 40/41 | €78,989 | €68,449 | -€10,540 | -13.3% |
| Trade receivables | 40 | €78,989 | €68,449 | -€10,540 | -13.3% |
| Cash at bank and in hand | 54/58 | €4,126 | €5,348 | +€1,222 | +29.6% |
| Deferred charges and accrued income | 490/1 | €2,522 | €2,522 | = | 0.0% |
| Total equity and liabilities | 10/49 | €85,637 | €76,319 | -€9,317 | -10.9% |
| Equity | 10/15 | -€7,446 | -€5,932 | +€1,514 | +20.3% |
| Reserves | 13 | €40,067 | €40,067 | = | 0.0% |
| Non-distributable reserves | 130/1 | €21,450 | €21,450 | = | 0.0% |
| Reserves not available under the articles | 1311 | €19,500 | €19,500 | = | 0.0% |
| Other | 1319 | €1,950 | €1,950 | = | 0.0% |
| Distributable reserves | 133 | €18,617 | €18,617 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€47,513 | -€45,999 | +€1,514 | +3.2% |
| Amounts payable | 17/49 | €93,082 | €82,251 | -€10,831 | -11.6% |
| Amounts payable within one year | 42/48 | €93,082 | €82,251 | -€10,831 | -11.6% |
| Trade debts | 44 | €2,191 | €119 | -€2,072 | -94.6% |
| Suppliers | 440/4 | €2,191 | €119 | -€2,072 | -94.6% |
| Taxes, remuneration and social security | 45 | €17,060 | - | -€17,060 | |
| Taxes | 450/3 | €0 | - | = | |
| Remuneration and social security | 454/9 | €17,060 | - | -€17,060 | |
| Other amounts payable | 47/48 | €73,831 | €82,132 | +€8,301 | +11.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €395 | - | -€395 | |
| Other operating charges | 640/8 | €2,312 | €2,285 | -€27 | -1.2% |
| Non-recurring operating charges | 66A | €9,631 | - | -€9,631 | |
| Gross operating margin | 9900 | €14,303 | €3,871 | -€10,431 | -72.9% |
| Operating profit (loss) | 9901 | €1,965 | €1,586 | -€379 | -19.3% |
| Financial charges | 65/66B | €133 | €72 | -€61 | -45.8% |
| Recurring financial charges | 65 | €133 | €72 | -€61 | -45.8% |
| Profit (loss) for the period before taxes | 9903 | €1,832 | €1,514 | -€318 | -17.4% |
| Profit (loss) for the period | 9904 | €1,832 | €1,514 | -€318 | -17.4% |
| Profit (loss) for the period to be appropriated | 9905 | €1,832 | €1,514 | -€318 | -17.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.